Jasper Ridge Partners’s Keros Therapeutics KROS Stock Holding History

Jasper Ridge Partners’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,042	Closed	-$220K	–	150
2022 Q1	$220K	Hold	4,042	–	–	0.01%	142
2021 Q4	$236K	Sell	4,042 -41,431	-91%	-$2.07M	0.01%	143
2021 Q3	$1.8M	Hold	45,473	–	–	0.08%	83
2021 Q2	$1.93M	Buy	+45,473	New	+$2.46M	0.1%	77

Other funds holding KROS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return